News and Press Releases
Sanofi announces launch of AVAXIM Junior in the UK for active immunisation against infection caused by the hepatitis A virus in children aged 12 months to 15 years
Reading, 24 April 2023. Sanofi (EURONEXT: SAN and NASDAQ: SNY) has today announced the launch of AVAXIM Junior in the UK, an inactive hepatitis A vaccine indicated for use in...
Category: Pharmaceutical
Posted: April 23, 2023
Sustainability takes centre stage for Tower Cold Chain at LogiPharma
Temperature-controlled specialist Tower is returning to LogiPharma in 2023 to showcase how pharmaceutical manufacturers are using its passive containers to improve their logistics infrastructure, in todayís sustainably inclined world.
Category: Logistics
Posted: April 19, 2023
Unit A, Total Park, Station Road, Theale, Reading, Berkshire RG7 4PN, UK
SAUDIA CARGO AGREEMENT WITH TOWER COLD CHAIN EXTENDS CHOICE IN MIDDLE EAST PHARMACEUTICAL SHIPMENTS
Saudia Cargo has added Tower Cold Chain to its approved roster of temperature-controlled containers for shipping pharmaceutical, biotech and life science products, in a new global rental agreement.
Category: Logistics
Posted: April 18, 2023
Unit A, Total Park, Station Road, Theale, Reading, Berkshire RG7 4PN, UK
Headlands Research Acquires Established Eastern Massachusetts‚Ä’Based Research Site Specializing in Neurodegenerative Diseases
San Francisco, CA, April 18, 2023 ó Headlands Research, a leading multinational network of clinical trial sites, today announced the acquisition of an established clinical research site, now known as...
Category: Clinical Trials
Posted: April 17, 2023
Pharmaceutical Industry Needs More Cross-Sector Collaboration
London, UK, 18 April 2023 / Sciad Newswire / The newly announced agenda for Connect in Pharma sends a strong message for more cross-sector collaboration. Technology gurus, consultancy experts and...
Category: Manufacturing and Packing
Posted: April 17, 2023
Bormioli Pharma reaffirms its commitment to environmental and social sustainability with the presentation of the 2nd edition of its ESG Report
Parma, 18 April 2023 - Bormioli Pharma, a leading international manufacturer of pharmaceutical packaging and medical devices, today presented the second edition of its Sustainability Report.
Category: Manufacturing and Packing
Posted: April 17, 2023
PCI Pharma Services Announces New Sterile Fill-Finish Capabilities Now Available in Melbourne and San Diego
PHILADELPHIA - April 18, 2023 -PCI Pharma Services (PCI), a leading global contract development and manufacturing organization (CDMO), today announced that three new state-of-the-art automated sterile fill-finish machines at its...
Category: Manufacturing and Packing
Posted: April 17, 2023
NeoPhore signs research collaboration with The Institute of Cancer Research, London
London, UK, 18 April 2023, - NeoPhore Limited, a small molecule neoantigen immuno-oncology company, today announces that it has signed a strategic collaboration agreement with Professor Chris Lordís lab at...
Category: Drug Discovery
Posted: April 17, 2023
3rd Floor, 1 Ashley Road, Altrincham, Cheshire WA14 2DT United Kingdom
Vaccitech Presents Interim Data from Phase 1b/2 Study of VTP-200 at 35th Annual International Papillomavirus Conference (IPVC) Highlighting Favourable Tolerability and Immunogenicity Profile
OXFORD, United Kingdom, 17 April, 2023 (GLOBE NEWSWIRE) - Vaccitech plc (NASDAQ: VACC), a clinical-stage biopharmaceutical company focused on the development of novel T cell immunotherapeutics designed to harness the...
Category: Clinical Trials
Posted: April 16, 2023
Transgene – Preclinical Results Showing TG6050, a Novel Oncolytic Virus, induces Tumor Regression by Activating Innate and Adaptive immune responses presented at AACR
Strasbourg, France, April 17, 2023, 7:30 a.m. CET - Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, presented promising preclinical...
Category: Drug Delivery
Posted: April 16, 2023
400 Boulevard Gonthier d’Andernach Parc d’Innovation – CS80166 67405 Illkirch-Graffenstaden
Phastar Supports Great Ormond Street Rare Disease Study Through Pro Bono Scheme
London, UK and Durham, NC - April 11, 2023: Specialist biometrics CRO Phastar has supported a Great Ormond Street Hospital-sponsored study into new treatments for children with severe combined immunodeficiency...
Category: Pharmaceutical Contractors
Posted: April 10, 2023
Innovative Trials Appoints First Commercial Vice President to Drive Business Growth Worldwide
Innovative Trials, a globally-focused company specializing in clinical trial patient recruitment, retention and engagement, has appointed Eloise Moffett to drive forward commercial activity in the US and beyond.
Category: Clinical Trials
Posted: April 5, 2023
Innovative House, Avenue One, Letchworth, Herts, SG6 2WW
WuXi STA Adds New Peptide Manufacturing Capacity and Large-Scale Continuous Purification System
Shanghai, China, 5 April 2023: WuXi STA, a global Contract Research, Development, and Manufacturing Organization (CRDMO), announces that it has added two 2,000 L reactors and a large-scale continuous purification...
Category: Manufacturing and Packing
Posted: April 4, 2023
288 Fute Zhong Road Waigaoqiao Free Trade Zone Shanghai 200131, China
CluePoints Announces Amit Patel as New CFO
King of Prussia, PA - April 5th, 2023: RBQM leader, CluePoints, has today announced that Amit Patel will join as the new Chief Financial Officer (CFO) amid ambitious growth plans...
Category: Clinical Trials
Posted: April 4, 2023
Mosaic Therapeutics closes $28m series A funding and appoints Brian Gladsden as CEO
Cambridge, UK, 04 April 2023 - Mosaic Therapeutics, Ltd, (ëMosaicí, or ëthe Companyí) an oncology therapeutics company dedicated to resolving cancerís complexity to power new treatments for patients, today announced...
Category: Drug Discovery
Posted: April 3, 2023
Mosaic Therapeutics Wellcome Genome Campus Cambridge CB10 1DR
